Enhancement of hematopoietic stem cell engraftment by inhibition of CXCL12 proteolysis with sitagliptin, an oral dipeptidyl-peptidase IV inhibitor: A report in a case of delayed graft failure

被引：6

作者：

Focosi, Daniele ^{[1
]}

Kast, Richard Eric ^{[2
]}

Metelli, Maria Rita ^{[3
]}

Benedetti, Edoardo ^{[1
]}

Galimberti, Sara ^{[1
]}

Papineschi, Federico ^{[1
]}

Petrini, Mario ^{[1
]}

机构：

[1] Univ Santa Chiara, Azienda Osped, Div Hematol, I-56100 Pisa, Italy

[2] Univ Vermont, Dept Psychiat, Burlington, VT 05401 USA

[3] Univ Santa Chiara, Azienda Osped, Dept Lab Med, I-56100 Pisa, Italy

来源：

LEUKEMIA RESEARCH | 2009年 / 33卷 / 01期

关键词：

BONE-MARROW-TRANSPLANTATION; HEMOPHAGOCYTIC SYNDROME; ALLOGENEIC TRANSPLANTATION; CD26; INFECTION; INFUSION;

D O I：

10.1016/j.leukres.2008.04.019

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：178 / 181

页数：4

共 22 条

[1]

Augustyns K, 1999, CURR MED CHEM, V6, P311

[2] G-CSF- and GM-CSF-induced upregulation of CD26 peptidase downregulates the functional chemotactic response of CD34+CD38- human cord blood hematopoietic cells [J].

Christopherson, Kent W., II ;

Uralil, Sherene E. ;

Porecha, Nehal K. ;

Zabriskie, Ryan C. ;

Kidd, Shannon M. ;

Ramin, Susan M. .

EXPERIMENTAL HEMATOLOGY, 2006, 34 (08) :1060-1068

[3] Modulation of hematopoietic stem cell homing and engraftment by CD26 [J].

Christopherson, KW ;

Hangoc, G ;

Mantel, CR ;

Broxmeyer, HE .

SCIENCE, 2004, 305 (5686) :1000-1003

[4] Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1α-mediated chemotaxis of human cord blood CD34+ progenitor cells [J].

Christopherson, KW ;

Hangoc, G ;

Broxmeyer, HE .

JOURNAL OF IMMUNOLOGY, 2002, 169 (12) :7000-7008

[5]

DAVIES SM, 1994, BONE MARROW TRANSPL, V14, P73

[6]

Focosi D, 2007, LANCET, V369, P269, DOI 10.1016/S0140-6736(07)60137-8

[7] Graft failure due to hemophagocytic syndrome after autologous peripheral blood stem cell transplantation [J].

Fukuno, K ;

Tsurumi, H ;

Yamada, T ;

Oyama, M ;

Moriwaki, H .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2001, 73 (02) :262-265

[8] Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1 [J].

Green, Brian D. ;

Irwin, Nigel ;

Duffy, Nicola A. ;

Gault, Victor A. ;

O'Harte, Finbarr P. M. ;

Flatt, Peter R. .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 547 (1-3) :192-199

[9] Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: Focus on sitagliptin [J].

Herman, G. A. ;

Stein, P. P. ;

Thornberry, N. A. ;

Wagner, J. A. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (05) :761-767

[10] Inhibition of the activity of dipeptidyl peptidase IV as a treatment for type 2 diabetes [J].

Holst, JJ ;

Deacon, CF .

DIABETES, 1998, 47 (11) :1663-1670

← 1 2 3 →